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Abstract: Consumption of kiwifruit is reported to relieve symptoms of functional 
gastrointestinal (GI) disorder. The effect may be related to the proteases in kiwifruit. This 
in vitro study aimed to measure protein hydrolysis due to kiwifruit protease under gastric 
and duodenal conditions. A sequence of experiments incubated meat protein, with and 
without kiwifruit, with varying concentrations of pepsin and hydrochloric acid, at 37 °C for 
60 min over the pH range 1.3–6.2 to simulate gastric digestion. Duodenal digestion was 
simulated by a further 120 min incubation at pH 6.4. Protein digestion efficiency was 
determined by comparing Kjeldahl nitrogen in pre- and post-digests. Where acid and pepsin 
concentrations were optimal for peptic digestion, hydrolysis was 80% effective and 
addition of kiwifruit made little difference. When pH was increased to 3.1 and pepsin 
activity reduced, hydrolysis decreased by 75%; addition of kiwifruit to this milieu more 
than doubled protein hydrolysis. This in vitro study has shown, when gastric pH is elevated, 
the addition of kiwifruit can double the rate of hydrolysis of meat protein. This novel finding 
supports the hypothesis that consumption of kiwifruit with a meal can increase the rate of 
protein hydrolysis, which may explain how kiwifruit relieves functional GI disorder. 
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Clinical evidence [1] supports the hypothesis that for some people, consumption of kiwifruit 
(Actinidia deliciosa, Hayward variety) relieves symptoms of gastrointestinal (GI) disorder such  
as indigestion, bloating and constipation. Occurring more frequently with ageing [2], constipation,  
a symptom of functional GI disorder [3], has a multifactorial etiology including enforced immobility, 
autoimmune responses, microbial influx, inflammatory bowel disease, a change of diet or an unbalanced 
diet, and some forms of medication (including analgesics, antibiotics and chemotherapeutics) [4]. It is 
common practice in both New Zealand hospitals and elder care homes to administer Kiwifruit juice in 
the form of Kiwi Crush™ to relieve and prevent constipation. Treatment of constipation, among patients 
at Wellington Hospital with Kiwi Crush™, was reported as an effective option to reduce frequency of 
constipation and use of other laxative products’ [5]. The daily inclusion of fresh kiwifruit in the diet of 
the elderly has also been reported to increase the frequency and ease of laxation [6,7]. Furthermore, a 
hospital audit has shown the efficacy of inclusion of kiwifruit in the diet for the management of 
functional GI disorder [8]. 
An unusual feature of the mature green-fleshed Hayward variety kiwifruit that is used exclusively 
in the production of Kiwi Crush™, is the presence of protein (about 3 g/kg of fruit). Approximately 
40% (≈1.2 g/kg of fruit) of the protein comprises a clade of six cysteine proteases, referred to collectively 
as actinidin [9]. The action of the proteases of kiwifruit under varying conditions of gastric digestion 
followed by duodenal digestion is not known. 
The aim of this study was to measure the rate of protein hydrolysis with and without the kiwifruit 
protease by varying in vitro conditions that simulate gastric and duodenal digestion to test the hypothesis 
that consumption of kiwifruit with a meal can increase the rate and extent of the hydrolysis of protein; 
a measure of protein digestion efficiency. 
2. Experimental Section 
A sequence of timed, in vitro, protein-digestion experiments was undertaken. Components of the 
digestion milieu were meat protein, kiwifruit protease, pepsin, hydrochloric acid and water. Gastric 
digestion was at 37 °C for 60 min over the pH range 1.3–6.2 to simulate gastric digestion. Duodenal 
digestion was simulated by a further 120 min incubation at pH 6.4. Total ammoniacal nitrogen (N) in 
the components of the digestate was determined by Kjeldahl analysis pre-digestion. Details of components 
and the sequence followed are described below. 
Each experimental run took almost six hours to complete and consisted of eight different treatments, 
plus a reference standard of meat protein in either water, 0.074 M HCl or 0.022 M HCl, with no added 
protease. The data from a run was discarded and repeated if the reference standard was more than 
±0.5% of the expected value. Each experimental run was repeated the following day and if the ammoniacal 
N in any individual treatment did not vary from its replicate by more than 2%, the outcome was accepted, 
otherwise the run was repeated.  
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2.1. Protein and Protease 
A homogenous freeze-dried, meat powder (FDM) was prepared from selected forequarter bovine 
shoulder steaks with a high component of connective tissue. All visible fat was trimmed and discarded 
and the meat double-passed through a 6-mm industrial mincing plate. The minced meat was boiled in 
water for 10 min and with the water, freeze-dried, milled to a powder and thoroughly mixed prior to 
packing into 50 g foil bags for refrigerated storage at −18 °C. The yield of FDM to wet weight of 
cooked meat pre drying was 30%, therefore 600 mg of FDM was equivalent to 2000 mg of hydrated 
cooked meat, the sample size recommended for Kjeldahl analysis [10]. 
Porcine pepsin (Sigma-Aldrich Australia, Product # P7125, with ≥400 Sigma units/mg protein, 
Sydney, Australia) was used to simulate human gastric pepsin. The other protease was the kiwifruit 
and we chose to use freeze-dried kiwifruit (Zyactinase® from Vital Food Processors Ltd., Auckland,  
New Zealand). This purer form of kiwifruit enzyme (KF) was chosen because it provided a shelf-stable, 
homogeneous product (water content < 4%). The protease activity of KF, measured using a casein 
substrate, was ≥3000 units/mg of protein (manufacturer’s specification).  
The protein concentration of each ingredient (FDM, pepsin and KF) was determined from six replicate 
Kjeldahl analyses (see section 2.3) of nitrogen, assuming a conversion factor of 6.25 g protein/g 
nitrogen. The mean concentrations of protein (g/100 g) and standard deviation for each were: FDM 
85.25 ± 0.32; pepsin 60.20 ± 1.75; and for KF 4.34 ± 0.09 respectively.  
2.2. Primary and Post-Primary Digestions 
The simple in vitro model digester used was comprised of 8 × 75 mL screw-top glass tubes held in 
a reciprocating flask shaker, set at 240 cycles per minute. The tubes were immersed in a 37 °C water 
bath. The sequence of experiments initially simulated ‘primary’ gastric digestion over a pH range 1.3 
to 6.1 and explored the effect of protease concentrations ranging from 5 to 40 mg ± 1% for pepsin and 
50 to 350 mg ± 1% for KF. Incubation-time effects on primary protein hydrolysis were also tested for 
KF over the range 15 to 120 min. The subsequent simulated “post-primary” duodenal digestion was 
fixed at pH 6.4 for 120 min. A 600 ± 0.5 mg sample of FDM and one or both proteases were weighed 
into each of eight glass tubes, a 20.0 mL aliquot of hydrochloric acid was added and the mixture incubated 
(37 °C) for 60 min for the primary digestion and an additional 120 min for the post-primary digestion. 
For the post-primary digestion pH was adjusted to 6.4 by adding phosphate buffered bicarbonate 
(0.074 M NaHCO3). After incubation, the mixtures were centrifuged at 2080 relative centrifugal force 
for 10 min and decanted into 250 mL Kjeldahl digestion tubes. Ammoniacal nitrogen in the supernatant 
was determined by the Kjeldahl method (see section 2.4). 
2.3. Determination of pH 
In the absence of a standard for gastric pH modeling, the AOAC recommended hydrogen ion 
concentration for gastric drug dissolution testing [11], 0.074 M-HCl with a calculated pH of 1.13 at 0 °C, 
was used to simulate an optimum gastric medium for peptic digestion. The addition of FDM and 
protease(s) increased the pH of the digests. Because of meter inaccuracies at low pH, where the measured 
pH was ≤3.0, the acidity of the gastric medium, prior to inclusion of the FDM and proteases, is 
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reported as a molar concentration (M). A PHM201 pH meter (Radiometer, Copenhagen, Denmark) 
was used to measure acidity where the pH exceeded 3.0.  
2.4. Measurement of Protein Hydrolysis by Kjeldahl  
After primary or post-primary digestion, the supernatant was decanted into 250 mL Kjeldahl tubes; 
the precipitate in the incubation tube was then washed with 10 mL of deionised water, re-centrifuged 
and that supernatant combined with the initial supernatant. A standard Kjeldahl digestion was followed 
using steam distillation equipment (UDK126A, VELP Scientifica, Usmate Velate (MB), Italy), trapping 
the distilled ammonia in boric acid, and titrating with standardised HCl using Tashiro’s indicator.  
2.5. Measurement of Protein Digestion Efficiency  
The fraction of protein hydrolysed expressed as percent ammoniacal N was calculated as: 
Fraction of protein hydrolysed = Hydrolysed protein in supernatant  
= Hydrolysed protein in supernatant × 100/ Total protein in FDM, pepsin, and KF 
 
After a 60 min incubation of 600 mg of FDM with no protease and 20 mL of either 0.074 M HCl, 
0.022 M HCl or deionized water, ammoniacal N in the supernatants were 12.95 ± 0.33%; 12.44 ± 0.59% 
and 12.6 ± 0.67%, respectively. On average, this would comprise about 12.5%, or 64 mg of the 512 mg of 
protein in 600 mg of FDM in each of the incubations (85.3% protein in FDM). The calculated 
contribution from pepsin at its standard rate (30 mg at 60.2% protein) would be a further 18 mg, and 
from KF at its standard rate (100 mg × 4.34% protein) would account for less than an additional 5 mg. 
Ammoniacal N in the supernatant was typically above 30%, to which pepsin and KF would thus make 
a minor contribution and were not considered in the calculation.  
2.6. Sequence of Experiments  
A series of five experiments sequentially explored the effects of varying (1) hydrogen ion concentration 
on the activity of a fixed concentration of KF and no pepsin; (2) KF concentration; (3) gastric 
incubation time; (4) pepsin concentration at two hydrogen ion concentrations; and (5) pepsin 
concentration with and without KF on the hydrolysis of FDM. 
2.7. Statistical Analysis 
Unless otherwise stated, data in the text are expressed as means of each treatment ±standard 
deviation (SD). Paired t tests determined differences between replicates and 95% confidence intervals 
(CI) of the mean determined. Overall the mean difference between replicates was −0.1418 ± 0.8402 
(95% CI −0.3775 to 0.0951, n = 49). Independent t tests were used to determine differences  
between conditions. Analyses were carried out using a combination of IBM® SPSS Statistics version 
19.0 (IBM Corp., New York, NY., USA. and Microsoft® Excel® Version 14.2.3 (Microsoft 
Corporation, Washington DC., USA).  




3.1. Effect of Hydrogen Ion Concentration on KF Activity 
With 600 mg of FDM, a 60-min incubation in 20 mL of 0.074 M HCl generated 13.56 and 12.94% 
ammoniacal N in the supernatant, in the presence and absence of 100 mg KF respectively (Table 1).  
The difference was just significant (p = 0.046). Thus KF was essentially inactive under these conditions. 
However, serial dilution of the HCl almost trebled the ammoniacal N in the supernatant, which 
reached 37.7% at 0.022 M HCl. The concentration subsequently declined to 27.7% in water alone.  
A concentration of 0.022 M HCl was chosen as the optimum concentration for KF protease activity. 
The yield of N in the supernatant from incubating 600 mg FDM in 0.022 M HCl for 60 min with no 
KF was an expected 12.60% ± 0.69%.  
Table 1. Effect of acid dilution on protein hydrolysis activity of kiwifruit protease  
(100 mg KF) on 600 mg of FDM (freeze dried meat) measured by the percentage of 
ammoniacal nitrogen in the supernatant of the hydrolysates after 60 min incubation at 37 °C. 
Concentration Ammoniacal N 
HCl:H2O HCl KF Mean 
(mL:mL) (M) (mg) (%) 
20:00 * 0.074 Nil 12.94 
20:00 0.074 100 13.56 
10:10 0.037 100 19.05 
9:11 0.034 100 29.12 
8:12 0.030 100 35.62 
7:13 0.026 100 36.67 
6:14 0.022 100 37.65 
5:15 0.019 100 37.04 
4:16 0.015 100 32.59 
3:17 0.011 100 30.93 
2.5:17.5 0.009 100 30.41 
1.25:18.75 0.005 100 30.00 
00:20 Nil 100 27.68 
00:20 Nil Nil 12.60 
The mean difference of all ammoniacal N replicates was 0.15%; 95% CI of difference −0.12 to 0.41; * The 
AOAC standard in vitro gastric molar concentration for drug dissolution testing. 
3.2. Effect of Changing Concentration of KF on Protein Hydrolysis at Optimal pH 
When the concentration of kiwifruit was sequentially increased from 0 to 350 mg in 20 mL of  
0.022 M-HCL (optimal acidity for KF activity) with 600 mg FDM and a 60-min incubation (Figure 1), 
hydrolysis progressively increased with the greatest rate of increase up to 100 mg KF and saturation 
occurring when more than 252 mg KF was added (Figure 1). The standard KF concentration in subsequent 
experiments was set at 100 mg per 600 mg FDM and 20 mL of HCl or water. 
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Figure 1. Effect of KF (kiwifruit protease) concentration (mg/digest) on protein hydrolysis 
of 600 mg FDM (freeze dried meat) measured by percentage of Kjeldahl nitrogen (N) in 
the supernatant after 60 min incubation in 20 mL 0.022 M HCl at 37 °C.  
 
3.3. Effect of Changing Incubation Time on Protein Hydrolysis  
Increasing the primary incubation time in 0.022 M HCL with 100 mg of KF but without pepsin 
increased supernatant ammoniacal N from 37.2% at 60-min to 44.1% at 120 min (Figure 2). Extending 
digestion for a further 60-min caused a negligible increase to 45.1%. However, extending the primary 
digestion for the same components in 0.074 M-HCl, the accepted gastric pH (AOAC recommendation), 
from 60 to 180-min increased N in the supernatant from 13.6% to 30%, this however could have been 
due to acid-catalysed hydrolysis with time rather than the effect of KF hydrolysis. 
Figure 2. Effect of incubation-time on hydrolysis of FDM (freeze dried meat) by KF 
(kiwifruit protease) measured by the percentage of ammoniacal nitrogen in the supernatant 
of the hydrolysate. The reaction mixtures contained 600 mg FDM, 20 mL of 0.022M HCl 
and 100 mg KF. 
 
Paired sample T-test Mean of difference = 0.124 ± 0.930; 95% CI of the difference −0.657 to 0.905. 
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3.4. Effect of Changing Pepsin Concentration on Protein Hydrolysis at Two Hydrogen Ion Concentrations 
The concentration of pepsin was sequentially increased from 5 to 40 mg in 20 mL of 0.074 M HCl, 
or 0.022 M HCL (optimal acidity for KF activity) with 600mg FDM and a 60-minute incubation 
(Figure 3). In 0.074 M HCl with 25 mg of pepsin, protein hydrolysis peaked at 80%. Further increases 
in pepsin concentration in two repeat experiments gave an average 80.16% ± 0.16% N in the 
supernatant for 25, 30, 35 and 40 mg pepsin. However, in 0.022 M HCl and more than 15 mg pepsin 
protein hydrolysis plateaued at 39%. Increasing the pepsin concentration had minimal effect, as the 
average over the range 25, 30, 35 and 40 mg of pepsin per 600 mg FDM was 39.49% ± 0.43%.  
A combination of low pepsin concentration (5 mg per 600 mg FDM) and low added acid concentration 
(0.022 M HCl) resulted in protein hydrolysis of 20.74% ± 0.70%. 
Figure 3. Effect of pepsin concentration on protein hydrolysis of 600 mg freeze-dried meat 
at two acid concentrations (0.022 M and 0.074 M HCl) measured by percentage of 
ammoniacal nitrogen in the supernatant of the hydrolysate after 60 min incubation at 37 °C. 
Points on the graph are means of duplicate digests and error are standard deviations 
 
3.5. Combined Effect of Pepsin and KF on Primary Hydrolysis of Protein. 
At the optimal pH for pepsin activity (from 0.074 M-HCl), 25 mg of pepsin and 600 mg of FDM, 
plus 100 mg of KF, resulted in about 80% hydrolysis (data not shown) similar to the effect of pepsin 
alone (Figure 3). In this high-acid environment, KF had little effect on hydrolysis. However, in the less 
acidic environment (0.022 M HCl), a combination of 5 mg pepsin and 100 mg of KF resulted in 
markedly increased hydrolysis. Thus, pepsin alone gave 20.7% ± 0.7% hydrolysis, and the further addition 
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of 100 mg KF increased the hydrolysis to 48.2 ± 0.3% (Figure 4). At higher pepsin concentrations, 10, 15 
and 30 mg/incubation in 20 mL of 0.022 M HCl, the addition of 100 mg of KF resulted in similar 
enhanced hydrolysis, up to 55.2% ± 1.2% of nitrogen in the supernatant with 30 mg of pepsin. 
Importantly, the greatest increase above pepsin alone was with 5 mg pepsin and 100 mg of KF where 
hydrolysis more than doubled the pepsin-alone value. In this experiment, each of the 0.022 M acid 
incubations with the FDM and enzyme additions resulted in a final pH of 3.1 ± 0.1 after 60 min. The 
addition of 600 mg of FDM to the 20 mL of 0.22 M HCl was the major factor influencing the change 
in pH from the theoretical 1.65 pH (−logH+ conc) of the acid alone to the measured 3.1 pH of the 
digest after 60 min incubation, whereas the addition of pepsin (5–30 mg) or KF (100 mg) had little 
effect on the pH of the digest. 
Figure 4. Effect on the hydrolysis of 600 mg of freeze-dried meat (FDM) after 60 min 
primary digestion with pepsin alone (red bars), or in combination with 100 mg of KF 
(purple bars). The green bars indicate the hydrolysis effect in 0.022 M HCl of 100 mg of KF on 
600 mg of FDM in the absence of pepsin. Incubations each contained 20 mL 0.022 M HCl, 
600 mg of FDM, plus various combinations of pepsin ranging from 0 to 30 mg/digest  




This in vitro study has shown that in elevated gastric pH conditions, such as may present with 
compromised gastric function, the addition of kiwifruit protease more than doubled the rate of 
hydrolysis of meat protein. This novel finding supports the hypothesis that consumption of kiwifruit 
with a meal can increase the rate and extent of the hydrolysis of protein. 
Evidence is also provided that when the added acid concentration decreased from 0.074 M to  
0.022 M (HCl), pepsin activity reduced by 50% and kiwifruit activity increased by 300%. 
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This evidence indicates that kiwifruit may exert its influence on digestion by increasing the extent of 
protein digestion in the gastric medium when the secretion of pepsin and/or hydrochloric acid is less than 
optimal. It is reported [12] in a study of 365 healthy subjects, average fasting gastric pH was 2.16 ± 0.11 
for men and 2.79 ± 0.18 for women, but in another study of 79 healthy elderly people [13], 11% of the 
participants recorded fasting gastric pH > 5.0 throughout the study. 
Another in vitro investigation of kiwifruit activity [14] has reported that when pH of the digestate 
was maintained at 1.9 with the aid of an automated acid pump, the digestion of beef muscle protein 
and protein from other sources, was enhanced. The magnitude of the total effect on protein hydrolysis 
is not reported, however the digestion of Troponin T was increased by 15%. 
The present study extends these finding across a range of pH, protease concentrations and incubation 
times and demonstrates kiwifruit protease achieves considerably greater activity at pH 3.1 compared 
with pH 1.9. An extensive literature search has found no other reports of kiwifruit activity under 
varying gastric pH conditions. 
Accurately measuring gastric acidity and pepsin concentration in vivo without inflicting patient 
distress, has limited the research on the efficiency of individual’s gastric protein digestion [15]. As a 
result there is no accepted standard for pH or enzyme concentrations for in vitro gastric studies. The 
AOAC 1995 standard for testing drug dissolution in an in vitro gastric medium [11], specifies 0.0744 
M HCl, which has a pH value of 1.13 before protein addition. Other researchers [16] have used similar 
acid concentration for protein digestion, as used in this present study. Takumi et al. (2000), selected 
0.1 M HCl (pH 1.0) for a pH-controlled study but emphasised the need to establish standard guidelines 
for in vitro gastric pH research [17].  
The study demonstrated that kiwifruit had little effect on post-primary digestion of meat protein 
hydrolysis where pH was 6.4, indicating the protease effect of kiwifruit on protein hydrolysis is more 
likely to occur in the stomach rather than the small intestine or the colon where the normal pH range is 
6.4–7.0. The activity decline observed, as pH increased above 3.6 supports the hypothesis that elevated 
gastric pH and pepsin insufficiency could be determining factors in kiwifruit’s effect on digestion.  
The increase in protein digestion efficiency, observed when KF concentration was increased, may 
indicate in vivo, where consumption of one kiwifruit fails to relieve digestive discomfort, increasing 
the dose might improve the outcome.  
If these in vitro results are replicated in vivo, this study indicates that kiwifruit is likely to exert its 
influence on digestion by increasing the extent of protein digestion in the gastric medium when the 
ratio of pepsin to substrate is less than optimal, and gastric pH is elevated to the extent that it 
compromises the activity of pepsin, but not to the extent that it inactivates the kiwifruit protease.  
There are a number of strengths and limitations in the study. One strength is that the conditions of 
the experiments are all within pathophysiological ranges such as might be found with functional  
GI disorder. The standard concentration of KF used in these experiments was 100 mg KF: 600 mg 
FDM. This is equivalent to 1250 mg of fresh kiwifruit to 2 g of meat. A medium sized kiwifruit  
will yield approximately 60g of flesh, which would provide the same KF concentration used in  
these experiments, for 96 g of meat. Assuming meat is 25%–30% protein and the daily requirement is  
1 g of protein/kg of body weight then one kiwifruit would provide treatment for 40% of the daily 
protein requirements of a 75 kg person based on the dose used in this study. 
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Selecting an appropriate baseline pH for in vitro studies of gastric digestion can be contentious as 
studies show that gastric pH varies significantly between individuals of similar age but more commonly 
between young and elderly people [13]. The starting point for this study was 0.074 M HCl and while a 
dynamic model to maintain gastric pH throughout the digestion was not used, restricting experiments 
to one acid concentration would have masked one of the more important findings of the study. The 
optimal acid concentration for KF activity was 0.022 M HCl (pH 1.66), before addition of FDM and 
protease, which together increased the pH to 3.1 after their addition. 
We do not know the specific rate of human pepsin production but it is estimated that a healthy adult 
secretes about 20,000 to 30,000 units of pepsin activity per day, which is thought to be about 10 mg 
equivalent of commercially available pepsin used for this in vitro study [18]. If an adult consumes 75 g 
of protein daily then the ratio of protein to pepsin is about 3 mg protein/unit of activity, or 10 g of 
protein: 0.18 mg of commercial pepsin. Our experiments used the equivalent of 1 g of protein to 10–60 mg 
of pepsin. The use of higher concentrations of enzyme to substrate for in vitro experiments is not 
uncommon. Porcine pepsin, as used in this study, has been observed to display greater activity than 
human pepsin [19]. As a result, in vivo hydrolysis by kiwifruit may vary from these in vitro results. 
These findings do not indicate why kiwifruit provides relief from the discomfort of functional 
gastrointestinal disorder but the following speculation attempts to provide a rationale for further testing 
of the hypothesis that kiwifruit provides relief of the symptoms of functional GI disorder.  
Primary protein digestion efficiency in vitro was determined by pepsin concentration and the acidity 
of the gastric milieu. Chronic gastritis, a condition not uncommon among the elderly [20], can result in 
hypochlorhydria (gastric acid insufficiency), while achlorhydria (an absence of gastric acid) represents 
the extreme outcome of gastritis. Even small variations in gastric pH and pepsin concentration in the 
present in vitro study had a marked influence on protein digestion efficiency and as acid and pepsin 
concentration were decreased, peptic protein hydrolysis became progressively less efficient. This is in 
agreement with a study on pH effects on pepsin activity conducted by Al-Janabi et al. (1972) that 
demonstrated pepsin activity on protein hydrolysis was 100 times faster at pH 1.0 than at pH 4.6 [21]. 
If the pH effect is replicated in vivo, this finding may have implications for some age associated 
diseases such as cancer, sarcopenia and reduced immune function [22,23]. 
The prevalence of elevated gastric pH is thought to be high in elderly people as a result of pathology 
and medication rather than physiology [24]. Constipation, a symptom of functional GI disorder, is also 
more prevalent amongst the elderly, possibly for the same reasons [25]. Whilst constipation, as an 
outcome of inefficient protein digestion, is not identified by Jahan-Mihan et al. [26] these researchers 
postulate that within the GI tract, peptide products of protein hydrolysis affect several regulatory functions.  
The mechanism they propose is that the peptide products stimulate receptors to initiate the secretion of 
hormones that affect gastric emptying and GI transport and absorption mechanisms as well as transmitting 
neural signals to the brain. The peptide products also have a modifying effect on the micro flora. These 
effects, combined with the finding that kiwifruit increases protein hydrolysis constrained by acidity and 
pepsin inadequacy (this study), and that kiwifruit relieves constipation [27,28], lends support to the 
hypothesis that kiwifruit relieves constipation by increasing gastric protein hydrolysis.  
The aim of treatment with proton pump inhibiting (PPI) medication is to maintain gastric acidity 
above pH 4 [29]. A concern expressed by a number of researchers [30,31] is that PPI treatment limits 
gastric hydrolysis of protein. This increases the loading on pancreatic and brush border protease 
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production. Failure of these secondary sources to compensate for inefficient primary gastric hydrolysis 
may have implications such as infectious complications and nutritional deficiencies. This is an area of 
proposed future research. 
Due in part to the invasive nature of current testing methods, regular measurement of individual’s 
fasting gastric pH and re-acidification efficiency are not currently a feature of routine health checks, 
making it conceivable that a pernicious deterioration in protein digestion efficiency over time could  
go undetected. If sarcopenia in the elderly results from a deterioration of protein assimilation rather 
than a dietary protein deficiency, this raises the possibility of inefficient peptic protein digestion as a 
contributing factor in the onset of sarcopenia, and possibly other age associated conditions.  
Extrapolations from the findings of this study and the literature reviewed, indicate that relief from 
functional GI disorder, associated with kiwifruit consumption, may be a result of three factors alone or 
in combination: first, improved gastric protein hydrolysis efficiency when gastric acidity is elevated; 
second, a reduction in the quantum of undigested protein entering the duodenum reducing reliance on 
pancreatic digestion to compensate for impaired gastric digestion; third, reduced protein in the chyme 
entering the colon, resulting in beneficial, compositional changes in gut micro-flora populations.  
5. Conclusions 
The consumption of kiwifruit with a meal may increase the rate of hydrolysis of protein, particularly if 
gastric pH is abnormally elevated, which may explain how kiwifruit relieves functional GI disorder. 
Further in vivo investigations of gastric digestion efficiency are warranted. 
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